These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Novel non-endocytic delivery of antisense oligonucleotides. Dokka S; Rojanasakul Y Adv Drug Deliv Rev; 2000 Oct; 44(1):35-49. PubMed ID: 11035196 [TBL] [Abstract][Full Text] [Related]
24. Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines. Linnane E; Davey P; Zhang P; Puri S; Edbrooke M; Chiarparin E; Revenko AS; Macleod AR; Norman JC; Ross SJ Nucleic Acids Res; 2019 May; 47(9):4375-4392. PubMed ID: 30927008 [TBL] [Abstract][Full Text] [Related]
25. Delivery of RNA Therapeutics: The Great Endosomal Escape! Dowdy SF; Setten RL; Cui XS; Jadhav SG Nucleic Acid Ther; 2022 Oct; 32(5):361-368. PubMed ID: 35612432 [TBL] [Abstract][Full Text] [Related]
26. The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking. Alam MR; Ming X; Dixit V; Fisher M; Chen X; Juliano RL Oligonucleotides; 2010 Apr; 20(2):103-9. PubMed ID: 20038250 [TBL] [Abstract][Full Text] [Related]
27. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides. Andaloussi SE; Lehto T; Lundin P; Langel U Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143 [TBL] [Abstract][Full Text] [Related]
28. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick? Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022 [TBL] [Abstract][Full Text] [Related]
29. Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice. Roberts J; Palma E; Sazani P; Ørum H; Cho M; Kole R Mol Ther; 2006 Oct; 14(4):471-5. PubMed ID: 16854630 [TBL] [Abstract][Full Text] [Related]
30. Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation. Miller CM; Wan WB; Seth PP; Harris EN Nucleic Acid Ther; 2018 Apr; 28(2):86-96. PubMed ID: 29437530 [TBL] [Abstract][Full Text] [Related]
31. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Mathew E; Hardee GE; Bennett CF; Lee KD Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441 [TBL] [Abstract][Full Text] [Related]
32. Cellular uptake and intracellular trafficking of oligonucleotides. Juliano RL; Carver K Adv Drug Deliv Rev; 2015 Jun; 87():35-45. PubMed ID: 25881722 [TBL] [Abstract][Full Text] [Related]
33. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis. Ming X Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985 [TBL] [Abstract][Full Text] [Related]
34. Incorporation of Endosomolytic Peptides with Varying Disruption Mechanisms into EGFR-Targeted Protein Conjugates: The Effect on Intracellular Protein Delivery and EGFR Specificity in Breast Cancer Cells. Lieser RM; Li Q; Chen W; Sullivan MO Mol Pharm; 2022 Feb; 19(2):661-673. PubMed ID: 35040326 [TBL] [Abstract][Full Text] [Related]